BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32447046)

  • 1. Chronic neutrophilic leukemia, a rare case of leukocytosis.
    Wang X; Resendes NM; Shanahan L; Hutchinson L; Woda B; Cerny J
    Leuk Res; 2020 Jul; 94():106384. PubMed ID: 32447046
    [No Abstract]   [Full Text] [Related]  

  • 2. Never judge a book by its cover: these neutrophils are not reactive!
    Rieu JB; Vergez F
    Blood; 2019 Aug; 134(7):656. PubMed ID: 31416815
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
    Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
    Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
    [No Abstract]   [Full Text] [Related]  

  • 4. Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent
    Gunawan AS; McLornan DP; Wilkins B; Waghorn K; Hoade Y; Cross NCP; Harrison CN
    Haematologica; 2017 Jun; 102(6):e238-e240. PubMed ID: 28302714
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly.
    Fathi AT; Graubert TA; Kulkarni NM; Kuo FC; Hasserjian RP
    N Engl J Med; 2016 Dec; 375(23):2273-2282. PubMed ID: 27959687
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in allele frequencies of
    Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
    Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.
    Langabeer SE; Haslam K; Kelly J; Quinn J; Morrell R; Conneally E
    Clin Transl Oncol; 2018 Mar; 20(3):420-423. PubMed ID: 28762112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.
    Stoner RC; Press RD; Maxson JE; Tyner JW; Dao KT
    Leukemia; 2020 Jun; 34(6):1684-1688. PubMed ID: 31844143
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
    Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic syndrome related to chronic neutrophilic leukemia.
    Wang R; Tong H; Wang H; Chen Z; Wang L; Chen J
    Intern Med; 2014; 53(21):2505-9. PubMed ID: 25366011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution in a chronic neutrophilic leukemia patient.
    Zhang QG; Wang J; Gong WY; Jing QC
    Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.
    Mc Lornan DP; Percy MJ; Jones AV; Cross NC; Mc Mullin MF
    Haematologica; 2005 Dec; 90(12):1696-7. PubMed ID: 16330446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
    Hinze A; Rinke J; Hochhaus A; Ernst T
    Ann Hematol; 2021 Feb; 100(2):581-584. PubMed ID: 32577845
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study.
    Elliott MA; Dewald GW; Tefferi A; Hanson CA
    Leukemia; 2001 Jan; 15(1):35-40. PubMed ID: 11243396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic neutrophilic leukemia associated with myeloma. Simultaneous presentation].
    Diéguez JC; Fernández Jurado A; Amián A; Rodríguez JN; Martino ML; Cañavate M; Prados D
    Sangre (Barc); 1992 Oct; 37(5):403-6. PubMed ID: 1293783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic neutrophilic leukemia associated with chronic lymphocytic leukemia.
    Ito K; Usuki K; Iki S; Urabe A
    Int J Hematol; 1998 Jul; 68(1):87-94. PubMed ID: 9713172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.
    Lasho TL; Mims A; Elliott MA; Finke C; Pardanani A; Tefferi A
    Leukemia; 2014 Jun; 28(6):1363-5. PubMed ID: 24445868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.